About Us FON Media Family Office News Luxury News FON Magazine FON Newsletters FON Videos FON Social Media Press Releases Marketplace Membership Contact Us Apply for FON+ FON+ Membership
Topic

Webinars

OXIO Health: Healthcare Post COVID – The New Paradigm, an Opportunity

Company: OXIO is disrupting the healthcare industry with a multifaceted approach to correct the complex flaws across the industry, from billing to patient care and…

Impact Venture Capital: Early-Stage Technology Venture Investment Opportunity for Family Offices

Impact Venture Capital is a Silicon Valley-based venture capital firm that invests alongside family offices and corporate venture groups into high growth technology startups.…

Akamara Therapeutics: Reimagining Immunotherapy for Cancer & Rare Disease

Novel scientific insights to unlock the full potential of B cell therapeutics Range of treatment opportunities for cancer immunotherapy and B cell-driven rare diseases…

Choice Housing Investments: Strong Returns in Multifamily Real Estate

Why Choice Housing Investments? The most recent completed quarter, gross annualized Cash on Cash returns were at 12.5% and the Preferred Return was delivered…

Verdego Aero: Leading the Electrification of the $1.2T Aerospace Industry

Background on Company The aerospace market is being disrupted by electrification, creating opportunities for new types of aircraft, improved economics, and lower emissions. Erik…

EPS Holdings: Get Off The Grid – The Future of Power Generation

BACKGROUND ON COMPANY EPS is a privately held, technology driven company that is focused on developing new power solutions through the manufacturing of highly…

Ecellix Battery Technologies: eCell™ is a breakthrough technology for the $100B Li-ion Battery Market

BACKGROUND ON COMPANY EPS is a privately held, technology driven company that is focused on developing new power solutions through the manufacturing of highly…

RMS: Addressing Diabetes, the Fastest Growing Disease in the World

BACKGROUND ON COMPANY Revolutionary cell therapy targeting a cure for both Type 1 and Type 2 diabetes Successful demonstration of curative properties in animal…

AgVest: Farmland Investing Provides Reliable Returns In Uncertain Times

Chris Brawner has been involved in over $650M in farmland investments over the past decade. Discover the benefits of investing in farmland during this…

Chromatix: The Biggest Thing To Happen To Color Since Pantone

Chromatix is an early stage company with proven patent portfolio of unique color changing chemistry that allows “color on demand” to provide a platform…

Protected by reCAPTCHA — the Google Privacy Policy and Terms of Service apply.